Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to...
Search for Articles
Mar 28, 2022
Mar 25, 2022
Renovacor Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Feb 28, 2022
Renovacor Announces Partnerships with the Dilated Cardiomyopathy Foundation
PHILADELPHIA--(BUSINESS WIRE)-- Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies...
Feb 9, 2022
HAYA Therapeutics Establishes U.S. Location
LAUSANNE, Switzerland & SAN DIEGO--(BUSINESS WIRE)--HAYA Therapeutics, SA, a company developing precision medicines that target...
Feb 4, 2022
CroíValve Raises an €8M Series A Round to Support a Feasibility Clinical Study Expands the Board of Directors and Leadership Team
Dublin, Ireland, 4 February 2022 – CroíValve, a Dublin based medical device company developing a...
Jan 24, 2022
Puzzle Medical Devices Inc. announces the closing of its major Seed financing round to support its first-in-human study
MONTREAL, January 24, 2022 /PRNewswire/ – Montreal based Puzzle Medical Devices Inc., a medical device...